UTILISATION DU DEXTRAN-SULFATE POUR LE TRAITEMENT DE IBMIR

European patent · EP1567171 · Deleted

Register entry

Publication number
EP1567171
Application number
EP03811973
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Nov 26, 2003
Published
Aug 31, 2005
Granted
Apr 18, 2007
Deleted
Nov 28, 2023
Reason
Maximum term reached
IPC classes
A61K 31/721 (2006.01)
A61P 37/06 (2006.01)
Priority
SE 0203526 28.11.2002
PCT application
PCT/SE2003/001830 26.11.2003
PCT publication
WO2004/047848 10.06.2004
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 28, 2023

    Maximum term reached

    Published in Swissreg on 28.11.2023

  2. Dec 1, 2022

    Change

    Published in Swissreg on 01.12.2022

  3. Sep 22, 2021

    Agent removed

    Representative
    Ing. Marco Zardi, c/o M. ZARDI & Co. S.A., via Pioda 6, 6900 Lugano (removed)

    Published in Swissreg on 22.09.2021

  4. Oct 23, 2009

    Agent entered

    Representative
    R. A. Egli & Co., Patentanwälte, Horneggstrasse 4, 8008 Zürich

    Published in Swissreg on 23.10.2009

  5. Jul 31, 2007

    Agent entered

    Representative
    Ing. Marco Zardi, c/o M. ZARDI & Co. S.A., via Pioda 6, 6900 Lugano

    Published in +pat+ No 14 in 2007

  6. May 15, 2007

    Granted

    Published in +pat+ No 9 in 2007

Parties

Holder

TX Medic AB

Box 81, 260 40 Viken, SE

Agent

R.A. Egli & Co, Patentanwälte

R. A. Egli & Co. Patentanwälte

Horneggstrasse 4, 8008 Zürich

Inventor

NILSSON, Bo

S-756 47 Uppsala, SE

KORSGREN, Olle

S-756 45 Uppsala, SE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.